CI
TMO icon

Capital International’s Thermo Fisher Scientific TMO Stock Holding History

Capital International’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6M Sell
45,947
-11,981
-21% -$6.5M 0.84% 37
2025
Q4 		$33.6M Buy
57,928
+1,855
+3% +$1.05M 1.18% 19
2025
Q3 		$27.2M Sell
56,073
-813
-1% -$378K 0.98% 29
2025
Q2 		$23.1M Sell
56,886
-2,409
-4% -$1.01M 0.88% 33
2025
Q1 		$29.5M Buy
59,295
+13,247
+29% +$7.17M 1.29% 20
2024
Q4 		$24M Sell
46,048
-4,609
-9% -$2.53M 0.98% 27
2024
Q3 		$31.3M Sell
50,657
-101
-0.2% -$59.8K 1.35% 19
2024
Q2 		$28.1M Sell
50,758
-5,162
-9% -$2.96M 1.29% 19
2024
Q1 		$32.5M Buy
55,920
+8,619
+18% +$4.84M 1.55% 14
2023
Q4 		$25.1M Sell
47,301
-2,155
-4% -$1.04M 1.29% 17
2023
Q3 		$25M Buy
49,456
+87
+0.2% +$46.4K 1.44% 14
2023
Q2 		$25.8M Buy
49,369
+61
+0.1% +$32.9K 1.44% 11
2023
Q1 		$28.4M Buy
49,308
+246
+0.5% +$139K 1.7% 6
2022
Q4 		$27M Buy
49,062
+1,346
+3% +$713K 1.86% 7
2022
Q3 		$24.2M Buy
47,716
+5,424
+13% +$3.04M 1.69% 9
2022
Q2 		$23M Sell
42,292
-470
-1% -$259K 1.73% 9
2022
Q1 		$25.3M Buy
42,762
+126
+0.3% +$72.4K 1.44% 10
2021
Q4 		$28.4M Sell
42,636
-38
-0.1% -$23.7K 1.44% 11
2021
Q3 		$24.4M Sell
42,674
-502
-1% -$276K 1.33% 12
2021
Q2 		$21.8M Buy
43,176
+1,722
+4% +$812K 1.2% 18
2021
Q1 		$18.9M Sell
41,454
-2,608
-6% -$1.24M 1.14% 18
2020
Q4 		$20.5M Buy
44,062
+1,022
+2% +$479K 1.2% 17
2020
Q3 		$19M Buy
43,040
+649
+2% +$268K 1.29% 19
2020
Q2 		$15.4M Sell
42,391
-384
-0.9% -$129K 1.44% 17
2020
Q1 		$12.1M Buy
+42,775
New +$13.5M 1.36% 19
2018
Q3 		– Sell
-15,199
Closed -$3.15M – 164
2018
Q2 		$3.15M Hold
15,199
– – 0.55% 60
2018
Q1 		$3.14M Buy
+15,199
New +$3.19M 0.56% 61

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International's TMO Position: Q1 2026 in Review

Capital International reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $6.5M and leaving 45,947 shares worth $22.6M. The position accounts for 0.84% of the portfolio, ranked #37.

Capital International first reported a position in TMO in Q1 2018 and has held it in 27 quarters since. The position peaked at $33.6M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Capital International held 45,947 shares of Thermo Fisher Scientific worth $22.6M as of Q1 2026.
  • Capital International sold 11,981 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.5M.
  • Thermo Fisher Scientific made up 0.84% of Capital International's portfolio in Q1 2026, its #37 holding.
  • Capital International first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 27 quarters since.
  • Capital International's Thermo Fisher Scientific position peaked at $33.6M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.